Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Fingolimod - Novel Therapy for Multiple Sclerosis



Loss of the protective myelin sheath

The neuron is the most important cell in the CNS and the peripheral nervous system. MS is characterised by the loss of the protective myelin sheath (demyelination).

  • Multiple sclerosis
    The main forms of multiple sclerosis (MS) are distinguished by their...
  • Loss of the protective myelin sheath
    The neuron is the most important cell in the CNS and the peripheral nervous...
  • MRI scan of a brain
    MRI scan of the brain of a person with MS. Lesions (light spots, arrowed) are...
  • Bladder control
    Damage to spinal cord nerves affecting the lower limbs is likely to be...
  • Cells involved in MS
    Major cells involved in the disease process in multiple sclerosis. Key: APC:...

Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Prexige - COX-2 Inhibitor
Prexige (lumiracoxib) is an innovative COX-2 inhibitor developed by...

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.